121 related articles for article (PubMed ID: 6218661)
1. Donor-specific transfusion with diminished sensitization.
Light JA; Metz S; Oddenino K; Strong DM; Simonis T; Biggers JA; Fernandez-Bueno C
Transplantation; 1982 Dec; 34(6):352-5. PubMed ID: 6218661
[TBL] [Abstract][Full Text] [Related]
2. Fresh versus stored blood in donor specific transfusion.
Light JA; Metz S; Oddenino K; Simonis T; Strong DM; Reinmuth B; Kumar J; Biggers JA
Transplant Proc; 1982 Jun; 14(2):296-301. PubMed ID: 6214058
[TBL] [Abstract][Full Text] [Related]
3. Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness.
Leivestad T; Thorsby E
Transplantation; 1984 Feb; 37(2):175-81. PubMed ID: 6198792
[TBL] [Abstract][Full Text] [Related]
4. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of risk factors for sensitization and early rejection episodes in a donor-specific transfusion plus azathioprine protocol.
Burlingham WJ; Stratta RJ; Mason B; Ambrust MJ; Kalayoglu M; Belzer FO; Sollinger HW
Transplantation; 1988 Feb; 45(2):342-5. PubMed ID: 3257833
[TBL] [Abstract][Full Text] [Related]
6. Improved renal allograft survival following donor-specific transfusions. II. In vitro correlates of early (DST-type) rejection episodes.
Burlingham WJ; Grailer A; Sparks-Mackety EM; Sondel PM; Sollinger HW
Transplantation; 1987 Jan; 43(1):41-6. PubMed ID: 2948309
[TBL] [Abstract][Full Text] [Related]
7. Optimization of donor specific blood transfusion in kidney transplantation.
Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL
Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891
[TBL] [Abstract][Full Text] [Related]
8. Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.
Burlingham WJ; Pan MH; Mason B; Ceman S; Sollinger HW
Transplantation; 1988 Jun; 45(6):1066-71. PubMed ID: 3289148
[TBL] [Abstract][Full Text] [Related]
9. Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion.
Cheigh JS; Suthanthiran M; Fotino M; Kaplan M; Evelyn M; Schechter N; Wolf CF; Riggio RR; Riehle R; Stubenbord WT
Uremia Invest; 1985-1986; 9(1):11-7. PubMed ID: 2940741
[TBL] [Abstract][Full Text] [Related]
10. A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients.
Sanfilippo FP; Bollinger RR; MacQueen JM; Brooks BJ; Koepke JA
Transfusion; 1985; 25(2):116-9. PubMed ID: 3885483
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with donor-specific blood transfusions in related recipients with high MLC.
Salvatierra O; Amend W; Vincenti F; Potter D; Iwaki Y; Opelz G; Terasaki P; Duca R; Hanes D; Cochrum KC; Hopper S; Feduska NJ
Transplant Proc; 1981 Mar; 13(1 Pt 1):142-9. PubMed ID: 6455788
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific transfusions. Donor-recipient HLA compatibility, recipient HLA haplotype, and antibody production.
Radvany RM; Patel KM
Transfusion; 1988; 28(2):137-41. PubMed ID: 3281335
[TBL] [Abstract][Full Text] [Related]
13. Two patterns of sensitization demonstrated by recipients of donor-specific transfusion. Limitations to control by Imuran.
Colombe BW; Lou CD; Salvatierra O; Garovoy MR
Transplantation; 1987 Oct; 44(4):509-15. PubMed ID: 3313837
[TBL] [Abstract][Full Text] [Related]
14. Successful renal transplantation of patients sensitized following deliberate unrelated blood transfusions.
Martin S; Dyer PA; Harris R; Manos J; Mallick NP; Gokal R; Johnson RW
Transplantation; 1985 Mar; 39(3):256-8. PubMed ID: 3883590
[TBL] [Abstract][Full Text] [Related]
15. Effect of pretransplant donor-specific transfusions in renal transplantation.
Leivestad T; Flatmark A; Hirschberg H; Thorsby E
Transplant Proc; 1982 Jun; 14(2):370-3. PubMed ID: 6214064
[No Abstract] [Full Text] [Related]
16. Induction of immune alterations and successful renal transplantation with a simplified method of donor-specific blood transfusion.
Cheigh JS; Suthanthiran M; Kaplan M; Evelyn M; Riggio RR; Fotino M; Schechter N; Wolf CF; Stubenbord WT; Stenzel KH
Transplantation; 1984 Nov; 38(5):501-6. PubMed ID: 6238460
[TBL] [Abstract][Full Text] [Related]
17. Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants.
Reed A; Pirsch J; Armbrust MJ; Burlingham WJ; Knechtle SJ; D'Alessandro AM; Sollinger HW; Lorentzen D; Kalayoglu M; Belzer FO
Transplantation; 1991 Feb; 51(2):382-4. PubMed ID: 1994532
[TBL] [Abstract][Full Text] [Related]
18. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy.
Salvatierra O; Melzer J; Potter D; Garovoy M; Vincenti F; Amend WJ; Husing R; Hopper S; Feduska NJ
Transplantation; 1985 Dec; 40(6):654-9. PubMed ID: 3907038
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
Haisa M; Sakagami K; Matsumoto T; Kawamura T; Uchida S; Fujiwara T; Shiozaki S; Inagaki M; Orita K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594
[No Abstract] [Full Text] [Related]
20. Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response.
Burlingham WJ; Sparks EM; Sondel PM; Glass NR; Belzer FO; Sollinger HW
Transplantation; 1985 Jan; 39(1):12-7. PubMed ID: 3155578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
